Valneva

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

501-1000 employees

Founded 2013

$67.8M post ipo equity

Biotechnology

Public Company

Website LinkedIn Email Facebook Twitter Share Tweet

Biotechnology Therapeutics Medical Health Care

Remote Work Available

This company offers remote work opportunities.

Open Positions3

Workable workplace: remote; Workable locations: United States. PennsylvaniaUnited States. New JerseyUnited StatesFull-TimeVaccine logisticsPosted

Senior Business Operations Manager

Align U.S. supply chain, finance, commercial, quality, and global teams on business operations and vaccine logistics.
Provide executive-level performance reporting and insights to the U.S. Head.
Lead government and private-market contracting operations, including financial analytics, compliance, and execution performance.
Own U.S. vaccine supply chain strategy and execution, and oversee 3PL distribution, cold-chain integrity, inventory, returns, and sales order administration.
Coordinate demand planning, transfer pricing, U.S. Customs, inventory optimization, and wholesaler and distributor engagement.
Direct pricing governance and contract administration, including distributor agreements, rebates, chargebacks, and customer compliance.
Calculate and submit U.S. government pricing reports, including NFAMP and FCP.
Oversee sales analytics and reporting, and partner with leadership on incentive compensation reporting and commercial performance tracking.
Work with Quality Assurance to maintain regulatory standards, mitigate operational risks, and improve efficiency and control.
Manage U.S. entity operations, including HR benefits oversight, vendors, fleet, office operations, onboarding, budgets, meetings, and training.

Business Operations

Showing 1 of 3 positions

Overview

Valneva develops, manufactures, and commercializes prophylactic vaccines for infectious diseases. The company currently markets three proprietary travel vaccines, including the chikungunya vaccine IXCHIQ®, the Japanese encephalitis vaccine IXIARO®, and the cholera vaccine DUKORAL®. IXCHIQ® is licensed in the United States, Canada, Europe, and Brazil. Valneva has a Lyme disease vaccine candidate (VLA15) in advanced clinical development, partnered with Pfizer, which is currently in Phase 3. The European Medicines Agency (EMA) has validated the Marketing Authorization Application for PF-07307405, a Lyme disease vaccine candidate. Valneva is also developing a second-generation Zika virus vaccine candidate, VLA1601, which initiated Phase 1 clinical trials in March 2024. The company's global manufacturing network includes sites in Livingston, Scotland; Solna, Sweden; and Vienna, Austria. Valneva was founded in 2013 through the merger of Intercell and Vivalis SA. It has been listed on Euronext Paris since May 2013 and on Nasdaq since May 2021. The company has raised a total of $854.07 million in funding across 16 rounds, with the last funding round occurring in September 2024. Pfizer invested $95 million in Valneva in June 2022.

Culture

Valneva has instituted a work-from-home policy for some roles and promotes flexible working hours and remote work options for a set number of days each week. For critical on-site functions such as R&D and manufacturing, the company implements strategies to promote social distancing. The company’s culture includes an emphasis on respect, dedication, motivation, integrity, agility, and results.

Technology

Valneva uses Google Cloud for hosting and Amazon S3 for CDN services. The company also uses DNSSEC, IPv6, and Amazon Route 53. Other technologies utilized include HTML5, Microsoft Outlook, Apache Server, Google Drive, Google Fonts, Wordpress, jQuery, Adobe Fonts, and Office 365.

Why Work Here

Valneva employs between 501 and 1000 individuals, with approximately 659 employees worldwide as of March 2026. The company's headquarters is in Lyon, France. The Senior Medical Science Liaison roles are remote and require an advanced degree such as MD, DO, PharmD, PhD, DNP, NP, PA, or MPH with substantial scientific/clinical experience, or an equivalent qualification. These roles require a minimum of five years of relevant experience in Medical Affairs, vaccines, infectious disease, clinical development, epidemiology, public health, or the biopharmaceutical industry. Three or more years of field medical/MSL experience is preferred. Expertise in vaccines, infectious diseases, epidemiology, travel medicine, and immunization policy is also required. Roles require autonomy, strategic prioritization, territory management, and operation in a matrix organization. Strong scientific communication, presentation, insight generation, and relationship management capabilities are also necessary. Extensive travel within the territory is required, with residence near a major airport preferred.

Benefits and Perks

Job postings indicate a team environment with good team spirit and highly motivated individuals. Valneva offers competitive benefits and flexible arrangements.

Tech Stack

widgetsserver

Similar Companies